Company / EPS (Diluted)
DarioHealth Corp. EPS (Diluted) History
FY2014-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$1.64
FY2018
5-year range
$1.64 / $3.84
FY2014-FY2018
Trend
-21.5%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3.84 to $1.64 over the past 2 years.
Based on SEC 10-K filings.
1.64 in FY2018 with a 3-year CAGR of -3.9%.
Declined from $3.84 to $1.64 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -3.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2018, eps (diluted) decreased 21.5% year-over-year.
- Peak eps (diluted) was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2018 | $1.64 | -21.5% |
| FY2017 | $2.09 | -45.6% |
| FY2016 | $3.84 | +107.6% |
| FY2015 | $1.85 | -51.3% |
| FY2014 | $3.80 | - |
As of FY2018 · SEC 10-K Annual Filings · Updated Jun 24, 2026